Biogen Inc. - Sep 26, 2023 Form 4 Insider Report for SANGAMO THERAPEUTICS, INC (SGMO)

Role
10%+ Owner
Signature
BIOGEN INC. By: /s/ Michael Dambach, Vice President and Treasurer
Stock symbol
SGMO
Transactions as of
Sep 26, 2023
Transactions value $
-$3,000,000
Form type
4
Date filed
9/28/2023, 05:30 PM
Previous filing
Aug 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGMO Common Stock Sale -$3M -6M -25.37% $0.50 17.7M Sep 26, 2023 By Biogen MA Inc. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Biogen Inc. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Shares are owned indirectly by Biogen Inc. and directly by its wholly-owned subsidiary Biogen MA Inc.